ABBOTT LABORATORIES — Director's Dealing 2014

Nov 13, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2014-09-30

Reporting Person: Contreras Jaime (Senior Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-09-30	Common shares without par value	I	16	$41.7533	Disposed	0	Indirect
2014-11-10	Common shares without par value	M	3100	$25.7555	Acquired	5146	Indirect
2014-11-10	Common shares without par value	M	3200	$26.6973	Acquired	8346	Indirect
2014-11-10	Common shares without par value	S	4200	$43.681	Disposed	4146	Indirect
2014-11-10	Common shares without par value	S	600	$43.683	Disposed	3546	Indirect
2014-11-10	Common shares without par value	S	400	$43.685	Disposed	3146	Indirect
2014-11-10	Common shares without par value	S	1100	$43.687	Disposed	2046	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-11-10	Option (right to buy)	$25.7555	M	3100	Disposed	2017-07-19	Common shares (3100)	Indirect
2014-11-10	Option (right to buy)	$26.6973	M	3200	Disposed	2018-02-14	Common shares (3200)	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	30136	Direct
Common shares without par value	20	Indirect
Common shares without par value	63903	Indirect
Common shares without par value	12081	Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of November 10, 2014.

F2: Held in the Jaime Contreras Marvan 2006 Living Trust. The reporting person is sole trustee of the trust. The trust is revocable.

F3: Held in spouse's living trust. The reporting person's spouse is sole trustee of the trust. The trust is revocable. The reporting person disclaims beneficial ownership of these securities.

F4: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.